S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
Log in

Neurotrope News Headlines (NASDAQ:NTRP)

$1.33
+0.08 (+6.40 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$1.24
Now: $1.33
$1.39
50-Day Range
$0.99
MA: $1.19
$1.45
52-Week Range
$0.63
Now: $1.33
$8.40
Volume756,500 shs
Average Volume1.84 million shs
Market Capitalization$17.38 million
P/E RatioN/A
Dividend YieldN/A
Beta2.03

Headlines

Neurotrope (NASDAQ NTRP) News Headlines

Source:
DateHeadline
Neurotrope IncNeurotrope Inc
www.bloomberg.com - February 16 at 5:30 PM
Zacks: Neurotrope Inc (NASDAQ:NTRP) Receives Average Rating of "Hold" from AnalystsZacks: Neurotrope Inc (NASDAQ:NTRP) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - February 13 at 6:47 PM
XpresSpa Appoints Robert Weinstein to Board of Directors - Yahoo FinanceXpresSpa Appoints Robert Weinstein to Board of Directors - Yahoo Finance
finance.yahoo.com - February 3 at 10:00 PM
Biogen And Neurotrope: Why Numbers Cannot Overcome Alzheimers Disease - Seeking AlphaBiogen And Neurotrope: Why Numbers Cannot Overcome Alzheimer's Disease - Seeking Alpha
seekingalpha.com - February 3 at 11:58 AM
Why I Love Trading A Small Account, And Why You Should Too - Yahoo FinanceWhy I Love Trading A Small Account, And Why You Should Too - Yahoo Finance
finance.yahoo.com - January 25 at 1:45 AM
Form 8-K Neurotrope, Inc. For: Jan 22 - StreetInsider.comForm 8-K Neurotrope, Inc. For: Jan 22 - StreetInsider.com
www.streetinsider.com - January 23 at 5:10 PM
EXPLAINER-Global airlines on high alert as virus outbreak spreads - NasdaqEXPLAINER-Global airlines on high alert as virus outbreak spreads - Nasdaq
www.nasdaq.com - January 23 at 6:26 AM
Some Great News for Potential Alzheimer’s Treatment - 24/7 Wall St.Some Great News for Potential Alzheimer’s Treatment - 24/7 Wall St.
247wallst.com - January 23 at 6:26 AM
Hairy situation: Scientists explain how stress-related graying occurs - NasdaqHairy situation: Scientists explain how stress-related graying occurs - Nasdaq
www.nasdaq.com - January 22 at 8:25 PM
Germany says swine fever case found just 12 km from its border - NasdaqGermany says swine fever case found just 12 km from its border - Nasdaq
www.nasdaq.com - January 22 at 3:24 PM
Neurotrope (NTRP) to Offer Stock - StreetInsider.comNeurotrope (NTRP) to Offer Stock - StreetInsider.com
www.streetinsider.com - January 22 at 3:24 PM
BUZZ-U.S. STOCKS ON THE MOVE-Neurotrope, Boeing, IBM, Express, Tesla - NasdaqBUZZ-U.S. STOCKS ON THE MOVE-Neurotrope, Boeing, IBM, Express, Tesla - Nasdaq
www.nasdaq.com - January 22 at 3:24 PM
Baudax Bio and Neurotrope among healthcare gainers; NanoViricides leads the losers - Seeking AlphaBaudax Bio and Neurotrope among healthcare gainers; NanoViricides leads the losers - Seeking Alpha
seekingalpha.com - January 22 at 3:24 PM
Mid-Afternoon Market Update: FuelCell Energy Falls On Downbeat Q4 Results; Neurotrope Shares Rise - BenzingaMid-Afternoon Market Update: FuelCell Energy Falls On Downbeat Q4 Results; Neurotrope Shares Rise - Benzinga
www.benzinga.com - January 22 at 3:24 PM
Neurotrope, Inc. Announces $18 Million Registered Direct Offering - Yahoo FinanceNeurotrope, Inc. Announces $18 Million Registered Direct Offering - Yahoo Finance
finance.yahoo.com - January 22 at 3:24 PM
Neurotrope Provides Corporate Update After Completing Bryostatin-1 Data Analysis for Advanced Alzheimers Disease Trial - Yahoo FinanceNeurotrope Provides Corporate Update After Completing Bryostatin-1 Data Analysis for Advanced Alzheimer's Disease Trial - Yahoo Finance
finance.yahoo.com - January 22 at 3:24 PM
Neurotrope, Inc. Announces $18 Million Registered Direct OfferingNeurotrope, Inc. Announces $18 Million Registered Direct Offering
finance.yahoo.com - January 22 at 3:24 PM
Neurotrope (NTRP) Provides Corporate Update After Completing Bryostatin-1 Data Analysis for Advanced Alzheimers Disease Trial - StreetInsider.comNeurotrope (NTRP) Provides Corporate Update After Completing Bryostatin-1 Data Analysis for Advanced Alzheimer's Disease Trial - StreetInsider.com
www.streetinsider.com - January 22 at 9:11 AM
Neurotrope Provides Corporate Update After Completing Bryostatin-1 Data Analysis for Advanced Alzheimers Disease Trial - PRNewswireNeurotrope Provides Corporate Update After Completing Bryostatin-1 Data Analysis for Advanced Alzheimer's Disease Trial - PRNewswire
www.prnewswire.com - January 22 at 9:11 AM
Neurotrope Provides Corporate Update After Completing Bryostatin-1 Data Analysis for Advanced Alzheimer's Disease TrialNeurotrope Provides Corporate Update After Completing Bryostatin-1 Data Analysis for Advanced Alzheimer's Disease Trial
finance.yahoo.com - January 22 at 9:11 AM
Acid Sphingomyelinase Deficiency Type C - Pipeline Review, H2 2019 - ResearchAndMarkets.com - Yahoo FinanceAcid Sphingomyelinase Deficiency Type C - Pipeline Review, H2 2019 - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - January 21 at 6:05 PM
Is Neurotrope, Inc. (NASDAQ:NTRP) A Volatile Stock? - Yahoo FinanceIs Neurotrope, Inc. (NASDAQ:NTRP) A Volatile Stock? - Yahoo Finance
finance.yahoo.com - December 19 at 5:17 PM
Is Neurotrope, Inc. (NASDAQ:NTRP) A Volatile Stock?Is Neurotrope, Inc. (NASDAQ:NTRP) A Volatile Stock?
finance.yahoo.com - December 19 at 5:17 PM
Form 10-Q Neurotrope, Inc. For: Sep 30 - StreetInsider.comForm 10-Q Neurotrope, Inc. For: Sep 30 - StreetInsider.com
www.streetinsider.com - November 12 at 8:30 AM
Neurotrope Announces Review of Strategic Alternatives to Maximize Shareholder ValueNeurotrope Announces Review of Strategic Alternatives to Maximize Shareholder Value
finance.yahoo.com - October 18 at 10:43 PM
BUZZ-U.S. STOCKS ON THE MOVE-Dominos Pizza, Neurotrope, Aphria, U.S.-listed Chinese stocks - NasdaqBUZZ-U.S. STOCKS ON THE MOVE-Domino's Pizza, Neurotrope, Aphria, U.S.-listed Chinese stocks - Nasdaq
www.nasdaq.com - October 8 at 4:23 PM
Neurotrope Announces Review of Strategic Alternatives to Maximize Shareholder Value - PRNewswireNeurotrope Announces Review of Strategic Alternatives to Maximize Shareholder Value - PRNewswire
www.prnewswire.com - October 8 at 4:23 PM
Mid-Morning Market Update: Markets Open Lower; Dominos Pizza Earnings Miss Expectations - BenzingaMid-Morning Market Update: Markets Open Lower; Domino's Pizza Earnings Miss Expectations - Benzinga
www.benzinga.com - October 8 at 11:22 AM
Zynex (ZYXI) Scales 52-Week High: Whats Driving the Stock? - Yahoo FinanceZynex (ZYXI) Scales 52-Week High: What's Driving the Stock? - Yahoo Finance
finance.yahoo.com - October 4 at 8:34 PM
Abbott (ABT) Gets FDA Nod for Spinal Cord Stimulation System - Yahoo FinanceAbbott (ABT) Gets FDA Nod for Spinal Cord Stimulation System - Yahoo Finance
finance.yahoo.com - October 1 at 3:42 PM
Abbott (ABT) Gets FDA Nod for Spinal Cord Stimulation SystemAbbott (ABT) Gets FDA Nod for Spinal Cord Stimulation System
finance.yahoo.com - October 1 at 3:42 PM
Boston Scientific (BSX) Upbeat on Results of EVOLVE Study - Yahoo FinanceBoston Scientific (BSX) Upbeat on Results of EVOLVE Study - Yahoo Finance
finance.yahoo.com - September 30 at 4:45 PM
Align Gains on Innovation Despite Poor Case Shipment in China - Yahoo FinanceAlign Gains on Innovation Despite Poor Case Shipment in China - Yahoo Finance
finance.yahoo.com - September 26 at 4:20 PM
Natera (NTRA) Scales 52-Week High: Whats Driving the Stock? - Yahoo FinanceNatera (NTRA) Scales 52-Week High: What's Driving the Stock? - Yahoo Finance
finance.yahoo.com - September 26 at 4:20 PM
Insulet Receives FDA Approval for ACE Pump Implementation - Yahoo FinanceInsulet Receives FDA Approval for ACE Pump Implementation - Yahoo Finance
finance.yahoo.com - September 24 at 4:11 PM
Neogen Forms Partnership With IGS to Enhance Beef Profile - Yahoo FinanceNeogen Forms Partnership With IGS to Enhance Beef Profile - Yahoo Finance
finance.yahoo.com - September 20 at 10:22 PM
Neogen Forms Partnership With IGS to Enhance Beef ProfileNeogen Forms Partnership With IGS to Enhance Beef Profile
finance.yahoo.com - September 20 at 10:22 PM
Will Neurotrope (NASDAQ:NTRP) Spend Its Cash Wisely?Will Neurotrope (NASDAQ:NTRP) Spend Its Cash Wisely?
finance.yahoo.com - September 20 at 10:22 PM
Zimmer Biomets New JuggerStitch to Grow Sports Medicine Line - Yahoo FinanceZimmer Biomet's New JuggerStitch to Grow Sports Medicine Line - Yahoo Finance
finance.yahoo.com - September 18 at 3:01 PM
Walgreens Retail Pharmacy Stays Firm Amid Reimbursement Woes - Yahoo FinanceWalgreens' Retail Pharmacy Stays Firm Amid Reimbursement Woes - Yahoo Finance
finance.yahoo.com - September 14 at 2:12 PM
U.S. STOCKS ON THE MOVE-Neurotrope, Callon Petroleum, Freds, AT&T, Sintx, Acadia, Changyou - NasdaqU.S. STOCKS ON THE MOVE-Neurotrope, Callon Petroleum, Fred's, AT&T, Sintx, Acadia, Changyou - Nasdaq
www.nasdaq.com - September 9 at 12:31 PM
Neurotropes Bryostatin-1 flunks mid-stage Alzheimers study; shares down 79% - Seeking AlphaNeurotrope's Bryostatin-1 flunks mid-stage Alzheimer's study; shares down 79% - Seeking Alpha
seekingalpha.com - September 9 at 12:31 PM
Neurotrope shares crash after Alzheimers drug fails in trial - ReutersNeurotrope shares crash after Alzheimer's drug fails in trial - Reuters
www.reuters.com - September 9 at 12:31 PM
Neurotrope Announces Top-line Results From Confirmatory Phase 2 Study of Bryostatin-1 in Moderate to Severe Alzheimers DiseaseNeurotrope Announces Top-line Results From Confirmatory Phase 2 Study of Bryostatin-1 in Moderate to Severe Alzheimer's Disease
finance.yahoo.com - September 9 at 12:31 PM
LivaNova's (LIVN) Study to Evaluate VNS Therapy Gets CMS NodLivaNova's (LIVN) Study to Evaluate VNS Therapy Gets CMS Nod
finance.yahoo.com - September 9 at 12:31 PM
Neurotrope shares crash after Alzheimer's drug fails in trialNeurotrope shares crash after Alzheimer's drug fails in trial
finance.yahoo.com - September 9 at 12:31 PM
Neurotrope Sees Hammer Chart Pattern: Time to Buy? - Yahoo FinanceNeurotrope Sees Hammer Chart Pattern: Time to Buy? - Yahoo Finance
finance.yahoo.com - September 5 at 2:45 PM
Is the Options Market Predicting a Spike in Neurotrope (NTRP) Stock? - NasdaqIs the Options Market Predicting a Spike in Neurotrope (NTRP) Stock? - Nasdaq
www.nasdaq.com - August 21 at 10:24 PM
Is the Options Market Predicting a Spike in Neurotrope (NTRP) Stock? - Yahoo FinanceIs the Options Market Predicting a Spike in Neurotrope (NTRP) Stock? - Yahoo Finance
finance.yahoo.com - August 21 at 11:38 AM
Is the Options Market Predicting a Spike in Neurotrope (NTRP) Stock?Is the Options Market Predicting a Spike in Neurotrope (NTRP) Stock?
finance.yahoo.com - August 21 at 11:38 AM
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Featured Article: What is a Buy-Side Analyst?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel